TREA

79253789 - STALICLA

Follow

Information

  • Trademark
  • 79253789
  • Serial Number
    79253789
  • Registration Number
    6026087
  • Filing Date
    November 16, 2018
    6 years ago
  • Registration Date
    April 07, 2020
    4 years ago
  • Transaction Date
    September 05, 2020
    4 years ago
  • Status Date
    April 07, 2020
    4 years ago
  • Published for Opposition Date
    January 21, 2020
    5 years ago
  • Location Date
    April 07, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KHAN, AHSEN M
  • Attorney Docket Number
    S21052000100
    Attorney Name
    Douglas R. Wolf, Esq.
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
STALICLA
Case File Statements
  • GS0051: Pharmaceutical and veterinary products, namely, pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; diagnostic medical products for medical use, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes; pharmaceutical healthcare preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; medicinal preparations and substances, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes and pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biochemical preparations for medical or veterinary used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical reagents for medical or veterinary use; biological reagents for medical or veterinary use, namely, biological preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biological preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biotechnological preparations in the nature of pharmaceutical preparations for medical use; biotechnological products in the nature of pharmaceutical preparations for medical use; diagnostic preparations for medical use; diagnostic or monitoring biomarker reagents for medical purposes used to treat autism spectrum disorder
  • GS0091: Data processing equipment, computing apparatus in the nature of computer hardware; downloadable computer spreadsheet and word processing software for general use; computer programs and systems for capturing, collecting, converting, analyzing, communicating, processing, receiving, recording, storing and transmitting data, images and information
  • GS0351: Business consulting; project management services for others for business purposes; compilation and management of databases and central data files in the field of medicine; creation of central data files in the nature of compiling data in the field of medicine other than for research purposes; compilation of statistics; collection and systemization of data in a central file; business information, namely, provision of commercial information in the field of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials; business information services in computer files and data banks, namely, compiling data regarding identification of links between autism spectrum disorder-related and non-autism spectrum disorder biomedical research data and to integrate domain specific large-scale genetic, molecular pharmacological and clinical data in order to define patient subgroups and to identify personalized treatments for business purposes; data processing services; business data analysis services; statistical and commercial analysis services for biomedical institutions and for medical and medical research institutions for business purposes; statistical and commercial analysis of technical data via computers for business purposes; computerized data processing; statistical and commercial data analysis services in the fields of public health, health care, bio-medicine as well as clinical trials for business purposes; compilation of information into computer databases for research and analysis in the fields of biomedicine and clinical trials
  • GS0421: Scientific and technological services, namely, research and design services relating to the development of therapeutic products; therapeutic product development featuring industrial analysis and research services; design and development of computer hardware and software; engineering services featuring technical data analysis services; pharmaceutical and biomedical research services; provision of non-downloadable software via a website for analysis in the fields of biomedical research, clinical trial data and clinical trials; provision of a non-downloadable web-based software used to access information in the fields of biomedical research and clinical trials as well as related data; provision of non-downloadable software via a database used to access biomedical research and clinical trial data; biomedical research services; provision of scientific research information in the fields of biomedicine and clinical trials; Therapeutic packages development featuring scientific data analysis services; design and development of software; medical research services; database design in the field of medicine
  • GS0441: Medical services, namely, medical analysis services; provision of information in the fields of medicine, health, and health care
  • TR0010: The wording "STALICLA" has no meaning in a foreign language.
Case File Event Statements
  • 9/5/2020 - 4 years ago
    38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/14/2020 - 4 years ago
    37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/14/2020 - 4 years ago
    36 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/7/2020 - 4 years ago
    35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/7/2020 - 4 years ago
    34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/21/2020 - 5 years ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/21/2020 - 5 years ago
    32 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/17/2020 - 5 years ago
    31 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/1/2020 - 5 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/1/2020 - 5 years ago
    29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/1/2020 - 5 years ago
    28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/16/2019 - 5 years ago
    27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/16/2019 - 5 years ago
    26 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/16/2019 - 5 years ago
    25 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/16/2019 - 5 years ago
    24 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/16/2019 - 5 years ago
    23 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/22/2019 - 5 years ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/22/2019 - 5 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/21/2019 - 5 years ago
    20 - ASSIGNED TO LIE Type: ALIE
  • 11/18/2019 - 5 years ago
    19 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 11/18/2019 - 5 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/18/2019 - 5 years ago
    17 - PETITION TO REVIVE-GRANTED Type: PETG
  • 11/18/2019 - 5 years ago
    16 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 11/6/2019 - 5 years ago
    15 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/6/2019 - 5 years ago
    14 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/29/2019 - 5 years ago
    13 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 10/21/2019 - 5 years ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 10/21/2019 - 5 years ago
    11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 9/12/2019 - 5 years ago
    10 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 4/12/2019 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/22/2019 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/22/2019 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/16/2019 - 5 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/13/2019 - 5 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/12/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/12/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/12/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/7/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR